U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07209202) titled 'Fructose Intestinal Gluconeogenesis' on Sept. 30.
Brief Summary: This study will test the hypothesis that within a defined range of fructose intake, the ability to convert fructose to glucose (via gluconeogenesis) in the small intestine plays a protective role for the liver, shielding it from the deleterious effects of fructose. We will investigate whether this protective effect of the intestine is impaired in individuals with obesity.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Obese But Otherwise Healthy Participants
Intervention:
OTHER: High fructose meal
Liquid meals containing 5...